Global WholeHealth Partners Corporation (GWHP)
Global WholeHealth Partners Corporation operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in San Clemente, CA, US. The stock last traded at $0.00, down 90.00% on the session, giving a market capitalisation of $1,313. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -69898.3%. Its beta of -11.47 implies it has historically moved less than the broad market.
Global WholeHealth Partners Corporation, established in 2013 and based in San Clemente, California, is dedicated to the development and distribution of a diverse array of in-vitro diagnostic test kits across the United States. The company provides swift diagnostic solutions, including rapid assays for CoVid-19, whole blood Ebola, whole blood Zika, and whole blood tuberculosis (TB), among other tests. These diagnostic tools are designed for wide accessibility, catering to both over-the-counter consumer purchases and professional point-of-care settings such as hospitals, physicians' offices, and various medical clinics. Their product line effectively identifies a multitude of diseases, encompassing infections like Ebola, Zika, dengue, malaria, influenza, tuberculosis, coronaviruses, and other conditions transmitted by vectors.
Global WholeHealth Partners Corporation is most often compared with the following Healthcare names: